Literature DB >> 2118400

Fish oil: a potent inhibitor of platelet adhesiveness.

X L Li1, M Steiner.   

Abstract

The effect of fish oil administration on platelet function was studied in eight normal individuals, four men and four women, who received fish oil equivalent to 6 g eicosapentaenoic acid per day for a period of 25 days. Platelet aggregation, platelet adhesion, phospholipid and fatty acid distribution were measured at periodic intervals before, during, and after the period of fish oil administration. Platelet aggregation induced by arachidonic acid, adenosine diphosphate, and collagen showed a moderate increase in ED 50 in response to the administration of fish oil. Conversely, platelet adhesion to fibrinogen and collagen I, which was studied at low shear rates in a laminar flow chamber, showed a striking 60% to 65% decrease after fish oil supplementation of the diet. The change in adhesiveness could be correlated with the pseudopodia formed in response to agonistic stimulation. Scanning electron microscopic examination of adherent platelets showed an overall reduction of pseudopodia that appeared short and stubby on fish oil administration. The profile of the fatty acids extracted from plasma confirmed compliance of the volunteers with their dietary supplements. Analysis of phospholipids showed changes in sphingomyelin, lysophosphatidylcholine, and phosphatidylcholine between pseudopodia and platelet cell bodies. Fish oil administration did not affect their overall distribution except for a moderate decrease in phosphatidylethanolamine in platelet pseudopodia. Changes were also recognized in the total fatty acids extracted from platelets, affecting primarily arachidonic acid, eicosapentaenoic acid, and docosahexaenoic acid. There were no changes in platelet adhesiveness in a group of five normal individuals who received a vegetable oil supplement of equal dose and duration as that of the fish oil. We conclude from these studies that fish oil, at least when administered over a limited period of time, is an effective inhibitor of platelet adhesiveness.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2118400

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  9 in total

1.  Risk of post-procedural bleeding in children on intravenous fish oil.

Authors:  Prathima Nandivada; Lorenzo Anez-Bustillos; Alison A O'Loughlin; Paul D Mitchell; Meredith A Baker; Duy T Dao; Gillian L Fell; Alexis K Potemkin; Kathleen M Gura; Ellis J Neufeld; Mark Puder
Journal:  Am J Surg       Date:  2016-12-01       Impact factor: 2.565

2.  Omega-3 fatty acids modulate collagen signaling in human platelets.

Authors:  M K Larson; G C Shearer; J H Ashmore; J M Anderson-Daniels; E L Graslie; J T Tholen; J L Vogelaar; A J Korth; V Nareddy; M Sprehe; W S Harris
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2010-12-22       Impact factor: 4.006

Review 3.  Omega-3 fatty acids. Current status in cardiovascular medicine.

Authors:  E B Schmidt; J Dyerberg
Journal:  Drugs       Date:  1994-03       Impact factor: 9.546

4.  Exogenous modification of platelet membranes with the omega-3 fatty acids EPA and DHA reduces platelet procoagulant activity and thrombus formation.

Authors:  Mark K Larson; Garth W Tormoen; Lucinda J Weaver; Kristen J Luepke; Ishan A Patel; Carl E Hjelmen; Nicole M Ensz; Leah S McComas; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2012-11-21       Impact factor: 4.249

5.  Dose-response effects of omega-3 on platelet aggregation: an observational study.

Authors:  Thomas Kander; Erik Lindblom; Ulf Schött
Journal:  J Int Med Res       Date:  2018-07-30       Impact factor: 1.671

6.  Importance of maintaining a low omega-6/omega-3 ratio for reducing platelet aggregation, coagulation and thrombosis.

Authors:  James J DiNicolantonio; James OKeefe
Journal:  Open Heart       Date:  2019-05-02

Review 7.  Cardiovascular, electrophysiologic, and hematologic effects of omega-3 fatty acids beyond reducing hypertriglyceridemia: as it pertains to the recently published REDUCE-IT trial.

Authors:  Omar Sheikh; Anthony G Vande Hei; Ayman Battisha; Tarek Hammad; Son Pham; Robert Chilton
Journal:  Cardiovasc Diabetol       Date:  2019-06-24       Impact factor: 9.951

8.  DHA 12-LOX-derived oxylipins regulate platelet activation and thrombus formation through a PKA-dependent signaling pathway.

Authors:  Adriana Yamaguchi; Livia Stanger; Cody J Freedman; Melissa Standley; Timothy Hoang; Reheman Adili; Wan-Chen Tsai; Christopher van Hoorebeke; Theodore R Holman; Michael Holinstat
Journal:  J Thromb Haemost       Date:  2020-12-16       Impact factor: 5.824

9.  Bleeding risk of dietary supplements: A hidden nightmare for cardiac surgeons.

Authors:  Harinder Singh Bedi; Vivek Tewarson; Kamal Negi
Journal:  Indian Heart J       Date:  2016-04-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.